Test Price
450 AED✅ Home Collection Available
Anti‑ssDNA Antibody Test in Dubai, UAE | 450 AED | DNA Labs UAE
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% clinical sensitivity and specificity via ISO 9001:2015 certified ELISA processing.
- VIP Mobile Phlebotomy: Temperature-controlled cold-chain home collection by specialized DHA-licensed nurses, available daily from 8 AM to 11 PM.
- Clinical Guidance: Post-result telephone consultation with a General Practitioner for structured result interpretation and clinical correlation.
- Insurance & Billing: Direct insurance coverage verification and cashless billing support available via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Anti‑ssDNA (Single-Stranded DNA) Antibody Test quantitatively measures immunoglobulin G (IgG) autoantibodies directed against single-stranded DNA using a high-sensitivity Enzyme-Linked Immunosorbent Assay (ELISA). This serological biomarker is primarily utilized as a supplementary diagnostic indicator in the evaluation of Systemic Lupus Erythematosus (SLE) and other systemic autoimmune rheumatic diseases. Clinical interpretation requires integration with the patient's complete serological profile, including anti‑dsDNA, anti‑Sm, Ro/SSA, La/SSB, and complement components C3/C4.
| Feature | DNA Labs UAE Service | Standard Market Alternative |
|---|---|---|
| Methodology | Recombinant antigen ELISA (CE-marked, ISO certified) | Conventional polyclonal ELISA |
| Laboratory Accreditation | ISO 9001:2015, DHA, MOHAP licensed | Non‑ISO / External referral lab |
| Turnaround Time (TAT) | Same-day result (by 9 PM for samples collected before 9 AM) | 2–3 business days |
Physician Insight & Safety Protocols
"As a General Practitioner with extensive experience in autoimmune serology interpretation, I emphasize that the Anti‑ssDNA antibody test is one component of a comprehensive diagnostic framework. A positive titer alone does not confirm disease; it must be rigorously correlated with the patient's clinical presentation, physical examination findings, and a panel of confirmatory autoantibodies. Patients must never adjust or discontinue prescribed immunosuppressive therapy based solely on laboratory results without direct consultation with their treating rheumatologist."
— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132
Critical Medication Advisory
Essential Safety Notice: Do not discontinue or modify your prescribed immunosuppressive medications prior to blood collection unless explicitly instructed by your treating physician. Immunosuppressive therapy can directly modulate autoantibody titers; therefore, accurate clinical interpretation of test results requires a complete and current medication history.
Clinical Exclusion Criteria & Emergency Red Flags
- Patients with active systemic infections or those receiving high-dose corticosteroids/immunosuppressants must inform the phlebotomist prior to sample collection, as these factors may transiently suppress or alter autoantibody levels.
- Uncorrected bleeding diathesis or known coagulopathy (INR > 3.0, platelet count < 50,000/µL) — please notify our clinical team before scheduling a home visit.
- If you are experiencing acute onset of severe arthralgia, unexplained persistent pyrexia, or a malar (butterfly) rash, proceed to the nearest emergency department immediately for urgent clinical evaluation.
Patient FAQ & Clinical Guidance
1. What does a positive Anti‑ssDNA antibody test result indicate?
A positive Anti‑ssDNA result indicates the presence of autoantibodies targeting single-stranded DNA. While this can signal systemic autoimmune activity—most commonly associated with Systemic Lupus Erythematosus (SLE) or mixed connective tissue disease—transient positivity may occur in infectious states or healthy individuals. This result must be interpreted alongside anti‑dsDNA, anti‑Sm, complement proteins (C3/C4), and urinalysis findings for accurate diagnostic stratification.
2. How does Anti‑ssDNA differ from Anti‑dsDNA antibody testing?
Anti‑ssDNA targets single-stranded DNA and is a relatively non-specific marker for SLE, often appearing in a broader spectrum of inflammatory and infectious conditions. In contrast, Anti‑dsDNA (double-stranded DNA) is a highly specific serological hallmark of SLE, particularly active lupus nephritis. Both tests are often ordered in parallel to provide a comprehensive autoantibody profile for differential diagnosis.
3. Is fasting or special preparation required for this test?
No fasting or special dietary preparation is required. The test is performed on a standard peripheral venous blood sample (serum or plasma). Patients are advised to maintain normal hydration and inform the phlebotomist of any current medications, particularly anticoagulants or immunosuppressants.
4. What is the turnaround time for the Anti‑ssDNA Antibody Test?
For samples collected via our VIP mobile phlebotomy service before 9:00 AM, the turnaround time is same-day. Results are typically compiled and securely uploaded to the patient portal by 9:00 PM. Stat orders can be accommodated with prior coordination.
UAE Regulatory & Data Privacy Adherence
- ✔ Data Protection: Fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) governing the processing of patient health information.
- ✔ Health ICT Compliance: Adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields for telemedicine and laboratory data handling.
- ✔ Clinical Safety: All specimen collection and patient consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
- ✔ Certification: ISO 9001:2015 certified (Certificate No: INT/EGQ/2509DA/3139) and fully licensed by the Dubai Health Authority (DHA Facility License: 1143).
Clinical & Logistical Metadata
| Test Name | Anti‑ssDNA (Single-Stranded DNA) Antibody Test |
| Price (AED) | 450 |
| Turnaround Time | Same-day (results by 9 PM for samples collected before 9 AM) |
| Sample Type / Matrix | Serum / Plasma (Peripheral Venipuncture) |
| Methodology Used | Enzyme-Linked Immunosorbent Assay (ELISA) |
| ICD-10-CM Code | M32.9 (Systemic lupus erythematosus, unspecified), M32.1, L93.0 |
| LOINC Code | 17831-9 (ssDNA Ab [Units/volume] in Serum) |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians